Kalhotra, P.; Chittepu, V.C.S.R.; Osorio-Revilla, G.; Gallardo-Velazquez, T.
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors. Molecules 2021, 26, 936.
https://doi.org/10.3390/molecules26040936
AMA Style
Kalhotra P, Chittepu VCSR, Osorio-Revilla G, Gallardo-Velazquez T.
Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors. Molecules. 2021; 26(4):936.
https://doi.org/10.3390/molecules26040936
Chicago/Turabian Style
Kalhotra, Poonam, Veera C. S. R. Chittepu, Guillermo Osorio-Revilla, and Tzayhri Gallardo-Velazquez.
2021. "Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors" Molecules 26, no. 4: 936.
https://doi.org/10.3390/molecules26040936
APA Style
Kalhotra, P., Chittepu, V. C. S. R., Osorio-Revilla, G., & Gallardo-Velazquez, T.
(2021). Field-Template, QSAR, Ensemble Molecular Docking, and 3D-RISM Solvation Studies Expose Potential of FDA-Approved Marine Drugs as SARS-CoVID-2 Main Protease Inhibitors. Molecules, 26(4), 936.
https://doi.org/10.3390/molecules26040936